XML 89 R67.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stockholders' Equity - Narrative (Details) - USD ($)
1 Months Ended 12 Months Ended
Jun. 30, 2022
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Apr. 30, 2023
Sep. 30, 2022
Jul. 29, 2022
Corporate Share Repurchase              
Stock repurchase program, authorized amount         $ 50,000,000    
Shares repurchased in period   $ 0 $ 0        
At-The Market Equity Offering              
Corporate Share Repurchase              
Sale of stock, authorized offering amount           $ 100,000,000  
Employee Stock Option              
Share-based Compensation Arrangement by Share-based Payment Award              
Weighted-average grant date fair value per share of stock options (in USD per share)   $ 36.65 $ 28.90 $ 80.08      
Intrinsic value of options exercised   $ 12,000,000 $ 4,600,000 $ 77,300,000      
Cash received from options exercised   $ 22,200,000 $ 2,600,000 $ 33,000,000      
2002 Stock Incentive Plan              
Share-based Compensation Arrangement by Share-based Payment Award              
Number of shares authorized (in shares)             300,000
2002 Stock Incentive Plan | Employee Stock Option              
Share-based Compensation Arrangement by Share-based Payment Award              
Increase the number of shares under the 2002 Stock Incentive Plan (in shares) 1,000,000            
Shares available for future option grants (in shares)   1,000,000          
Unrecognized compensation cost   $ 26,200,000          
Weighted-average period in which cost is expected to be recognized (in years)   2 years 6 months          
2002 Stock Incentive Plan | Restricted stock              
Share-based Compensation Arrangement by Share-based Payment Award              
Weighted-average period in which cost is expected to be recognized (in years)   1 year 7 months 6 days          
Unrecognized compensation cost, restricted stock   $ 15,200,000          
Omniab Separation | Employee Stock Option              
Share-based Compensation Arrangement by Share-based Payment Award              
Unrecognized compensation cost   $ 1,100,000          
Weighted-average period in which cost is expected to be recognized (in years)   10 months 24 days          
Omniab Separation | Restricted stock              
Share-based Compensation Arrangement by Share-based Payment Award              
Weighted-average period in which cost is expected to be recognized (in years)   1 month 6 days          
Unrecognized compensation cost, restricted stock   $ 100,000          
Amended ESPP              
Share-based Compensation Arrangement by Share-based Payment Award              
Shares available for future option grants (in shares)   30,801          
Employee Stock Purchase Plan              
Shares allowed to purchase in employee stock purchase plan per employee (in shares)   1,250          
Proportion of fair market value of common stock at which stock is purchased under ESPP (as a percent)   85.00%          
Initial Offering Period   6 months          
Common stock issued under amended ESSP (in shares)   5,080 8,479 8,448